Non-linear dose-response relationship between the visceral adiposity index and diabetes in adults with normoglycemia: a cohort study
View abstract on PubMed
Summary
This summary is machine-generated.The visceral adiposity index (VAI) is linked to increased diabetes risk in Japanese adults. Reducing VAI, especially below 4.67, may significantly lower the chances of developing type 2 diabetes.
Area Of Science
- Metabolic Health
- Diabetes Epidemiology
- Obesity Research
Background
- Previous research indicates a connection between visceral adiposity index (VAI) and diabetes.
- This study specifically investigates this association within a normoglycemic adult population in Japan.
Purpose Of The Study
- To examine the relationship between the visceral adiposity index (VAI) and the incidence of diabetes in Japanese adults.
- To determine if the association is linear or non-linear and assess the predictive value of VAI for diabetes development.
Main Methods
- A longitudinal cohort study (NAGALA) was conducted from 2004 to 2015 in Japan.
- Multivariate Cox regression, restricted cubic spline (RCS) models, and ROC curve analysis were employed.
- The study analyzed data from 15,452 normoglycemic adults.
Main Results
- A positive, non-linear association was found between VAI and incident diabetes (HR=1.13).
- An inflection point was observed at VAI=4.67; values below this showed a stronger association (HR=1.24 per unit increase).
- The association was more pronounced in women, and VAI demonstrated good predictive power (AUC=0.7479).
Conclusions
- The study confirms a positive, non-linear link between VAI and diabetes in Japanese adults.
- A VAI below 4.67 indicates a critical threshold where VAI reduction can significantly decrease diabetes risk.
- The findings highlight VAI as a valuable marker for diabetes risk, particularly in women.
Related Concept Videos
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

